Structure Therapeutics Inc. Shares Outstanding (Cover Page)
Structure Therapeutics Inc. (GPCR) had Shares Outstanding (Cover Page) of 213.93 million shares as of 2026-07-31, per its 10-Q filed 2026-08-06.
Financial Statements › Notes › Cover Page
dei:EntityCommonStockSharesOutstanding · last filed 2026-08-06
- 2026-07-31: Entity Common Stock, Shares Outstanding 213.93M shares.
- 2026-04-30: Entity Common Stock, Shares Outstanding 213.22M shares.
- 2026-02-15: Entity Common Stock, Shares Outstanding 212.53M shares.
- 2025-10-31: Entity Common Stock, Shares Outstanding 182.03M shares.
| Period end | Entity Common Stock, Shares Outstanding |
|---|---|
| 2026-07-31 | 213.93M shares 10-Q · filed 2026-08-06 |
| 2026-04-30 | 213.22M shares 10-Q · filed 2026-05-07 |
| 2026-02-15 | 212.53M shares 10-K · filed 2026-02-26 |
| 2025-10-31 | 182.03M shares 10-Q · filed 2025-11-06 |
| 2025-07-31 | 172.79M shares 10-Q · filed 2025-08-06 |
| 2025-04-30 | 172.61M shares 10-Q · filed 2025-05-08 |
| 2025-01-31 | 172.03M shares 10-K · filed 2025-02-27 |
| 2024-10-31 | 171.78M shares 10-Q · filed 2024-11-13 |
| 2024-07-31 | 171.59M shares 10-Q · filed 2024-08-08 |
| 2024-04-30 | 139.86M shares 10-Q · filed 2024-05-09 |
| 2024-02-29 | 139.79M shares 10-K · filed 2024-03-08 |
| 2023-10-31 | 139.16M shares 10-Q · filed 2023-11-17 |
| 2023-08-03 | 114.81M shares 10-Q/A · filed 2023-11-17 |
| 2023-05-10 | 114.80M shares 10-Q · filed 2023-05-11 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Spyre Therapeutics, Inc. (SYRE) | United States | $7.685B | -43.69 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |